We are applying to become a collaborative treatment site for the NIDA-sponsored clinical trial comparing the efficacy of Supportive-Expressive Psychotherapy, Cognitive Behavior Therapy, and/or Drug Counseling in cocaine abuse disorders. In addition to conducting the comparative trial (as finalized by the steering committee), we propose a comprehensive investigation of the reliability, stability, and clinical significance of affective disorder diagnoses in cocaine abusers. This substudy has considerable public health significance: while affective disorders are apparently common in cocaine abusers (lifetime prevalence of up to 50%), the reliability of such diagnoses is questionable, their etiopathogenesis is poorly understood, and their implications for treatment planning remain controversial. Features of our substudy include: collection of life-time history and time-course of affective symptoms in relation to cocaine abuse; re-ratings of videotaped interviews and repeat interviews after 1 and 6 months to determine reliability and temporal stability; use of an alternate diagnostic format (SADS) to establish convergent validity; and construct validation of affective disorders diagnoses using the RDC Family History method. In addition, psychotherapy/counseling nonresponders will enter an 8-week placebo-controlled study of the efficacy of desipramine hydrochloride (DMI), with patients stratified by therapy assignment and presence/absence of affective disorder. We hypothesize that cocaine abusers with comorbid affective disorder will have less extensive drug abuse histories, less personality pathology, greater familial risk of affective disorder, superior response to psychotherapy, and lower rates of cocaine use during follow-up. Further, we hypothesize a disaggregation of affective disorder cases into primary and secondary subtypes (on the basis of the temporal sequence of onset in relation to cocaine abuse). We predict that primary depressives will show: earlier onset of depression, less drug exposure, lower levels of intercurrent life stress, more classical signs of melancholia, lower familial risk of substance abuse and higher risk -of affective disorder, more favorable response to DMI, and greater risk of depressive relapse despite abstinence from cocaine. This substudy will yield a wealth of information about the diagnosis and treatment of depression in cocaine abusers, which promises to result in refinements in classification and improved application of the differential therapeutics of these comorbid conditions. These findings thus are likely to lead to a better match between patients and available treatments of cocaine dependence (i.e., drug counseling, professional psychotherapy, and antidepressant pharmacotherapy).

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Demonstration--Cooperative Agreements (U18)
Project #
5U18DA007673-02
Application #
2120153
Study Section
Special Emphasis Panel (SRCD (06))
Project Start
1991-09-30
Project End
1995-08-31
Budget Start
1992-09-01
Budget End
1993-08-31
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Psychiatry
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Najavits, Lisa M; Harned, Melanie S; Gallop, Robert J et al. (2007) Six-month treatment outcomes of cocaine-dependent patients with and without PTSD in a multisite national trial. J Stud Alcohol Drugs 68:353-61
Najavits, Lisa M; Runkel, Ragna; Neuner, Christina et al. (2003) Rates and symptoms of PTSD among cocaine-dependent patients. J Stud Alcohol 64:601-6
Najavits, L M; Weiss, R D; Reif, S et al. (1998) The Addiction Severity Index as a screen for trauma and posttraumatic stress disorder. J Stud Alcohol 59:56-62
Siqueland, L; Crits-Christoph, P; Frank, A et al. (1998) Predictors of dropout from psychosocial treatment of cocaine dependence. Drug Alcohol Depend 52:1-13
Crits-Christoph, P; Siqueland, L; Chittams, J et al. (1998) Training in cognitive, supportive-expressive, and drug counseling therapies for cocaine dependence. J Consult Clin Psychol 66:484-92
Najavits, L M; Gastfriend, D R; Nakayama, E Y et al. (1997) A measure of readiness for substance abuse treatment. Psychometric properties of the RAATE-R interview. Am J Addict 6:74-82
Crits-Christoph, P; Siqueland, L; Blaine, J et al. (1997) The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Arch Gen Psychiatry 54:721-6